fashion -WSS

fashion

author：hotspot 2025-10-01 14:14:57 - browse：1692

Roche HQ — SEBASTIEN BOZON/AFP via Getty Images

The multibillion-dollar hunt for what many drugmakers hope will be the next big immunotherapy target has had no shortage of twists and tea-leaf-reading. In the wee hours of Wednesday morning, it got another.

Roche confirmed it accidentally released interim data from a closely watched clinical trial testing whether blocking that target — a protein on T cells known as TIGIT — can enable non-small lung cancer patients to live longer than standard immunotherapy alone.

The announcement release came hours after Evercore analyst Umer Raffat emailed investors that he had found a presentation on a Roche media portal, presumably uploaded by accident.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： HPV cancer vaccine study demonstrates efficacy

WSS

How a symptom of dementia informs our understanding of creativity

Australia’s approach to dialysis celebrates life

Psilocybin's anti

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Psilocybin's anti

FDA panel gives mixed vote on blood pressure devices

explore

fashion

leisure time

The cancer drug shortage isn’t new — and neither are the solutions

FDA panel gives mixed vote on blood pressure devices

Psychedelics group wrestles with new pharma identity

In science, is the line between industry and academia shifting?

Peter Hotez and the public health issue of online harassment

White House calls on federal agencies to crack down on AI abuses

ChatGPT in medicine: STAT answers readers' burning questions

Medicare will require more price transparency from hospitals

Supreme Court strikes down use of affirmative action

Extreme heat events are a public health emergency

hotspot

The Sacklers, horror, and ‘The Fall of the House of Usher’

Study finds new variant for Parkinson’s in African populations

Victims of gun violence feel impacts long after bullet wound

Australia’s approach to dialysis celebrates life

AstraZeneca challenges Medicare drug negotiation program

HPV cancer vaccine study demonstrates efficacy

leisure time

hotspot

knowledge

hotspot